Publications

5538 Results

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099.

Authors
M Al-Sarraf;M LeBlanc;PGS Giri;KK Fu;J Cooper;T Vuong;AA Forastiere;G Adams;WA Sakr;DE Schuller;JF Ensley
Journal / Conference
Journal of Clinical Oncology 16(4):1310-1317
Year
1998
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817)

Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: Value of augmented preparative regimens-A Southwest Oncology Group trial.

Authors
PJ Stiff;S Dahlberg;SJ Forman;AR McCall;SJ Horning;AP Nademanee;KG Blume;M LeBlanc;RI Fisher
Journal / Conference
Journal of Clinical Oncology 16(1):48-55
Year
1998
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8942

A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma and rhabdomyosarcoma.

Authors
K Antman;J Crowley;SP Balcerzak;RA Kempf;RB Weiss;GH Clamon;LH Baker
Journal / Conference
Cancer 82(7):1288-1295
Year
1998
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-8616 (INT-0072)

Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: An intergroup study.

Authors
CW Taylor;S Green;WS Dalton;S Martino;D Rector;JN Ingle;NJ Robert;GT Budd;JC Paradelo;RB Natale;JD Bearden;JA Mailliard;CK Osborne
Journal / Conference
Journal of Clinical Oncology 16(3):994-999
Year
1998
Research Committee(s)
Breast
Study Number(s)
SWOG-8692 (INT-0075)

Expanded phase II trial of paclitaxel in metastatic breast cancer: A Southwest Oncology Group study.

Authors
CE Geyer Jr;SJ Green;CM Moinpour;J O'Sullivan;DK Goodwin;VA Canfield;FJ Meyers;CK Osborne;S Martino
Journal / Conference
Breast Cancer Research and Treatment 51:169-181
Year
1998
Research Committee(s)
Breast
Study Number(s)
SWOG-9248

HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: A Southwest Oncology Group study.

Authors
RM Elledge;S Green;D Ciocca;R Pugh;DC Allred;GM Clark;J Hill;P Ravdin;J O'Sullivan;S Martino;CK Osborne
Journal / Conference
Clinical Cancer Research 4:7-12
Year
1998
Research Committee(s)
Breast
Study Number(s)
SWOG-9314

Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: A Southwest Oncology Group study.

Authors
KA Margolin;PY Liu;LE Flaherty;JA Sosman;MJ Walker;JW Smith II;WS Fletcher;GR Weiss;JM Unger;VK Sondak
Journal / Conference
Journal of Clinical Oncology 16(2):664-669
Year
1998
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9348

Evaluation of topotecan in resistant and relapsing multiple myeloma: A Southwest Oncology Group study.

Authors
EH Kraut;JJ Crowley;JL Wade;LR Laufman;M Alsina;SA Taylor;SE Salmon
Journal / Conference
Journal of Clinical Oncology 16(2):589-592
Year
1998
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9237

Phase II trial of recombinant human interleukin-4 in patients with disseminated malignant melanoma: A Southwest Oncology Group study.

Authors
RP Whitehead;JM Unger;JW Goodwin;MJ Walker;JA Thompson;LE Flaherty;VK Sondak
Journal / Conference
Journal of Immunotherapy 21(6):440-446
Year
1998
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9228

Interferon versus interferon plus prednisone remission maintenance therapy for multiple myeloma: A Southwest Oncology Group study.

Authors
SE Salmon;JJ Crowley;SP Balcerzak;RW Roach;SA Taylor;SE Rivkin;W Samlowski
Journal / Conference
Journal of Clinical Oncology 16(3):890-896
Year
1998
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9028